BioNTech SE Catalyst Calendar
Proactively evaluate BioNTech SE’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of BioNTech SE Catalyst Calendar data
| Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
|---|---|---|---|---|---|---|---|
| 28 Apr 2020 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
| 31 Dec 2019 | CTA Filing (EU) | BioNTech US Inc | - | BNT-221 | Oncology | Solid Tumor | Company Press Release |
| 31 Dec 2019 | Phase I Trial Results | BioNTech SE; Bristol-Myers Squibb Co | BMY; BNTX | NEOPV-01 | Oncology | Bladder Cancer; Carcinomas; Lung Cancer; Melanoma; Non-Small Cell Lung Carcinoma; Skin Cancer; Transitional Cell Carcinoma (Urothelial Cell Carcinoma); Ureter Cancer; Urethral Cancer | Company Press Release |
| 31 Dec 2019 | CTA Filing (EU) | BioNTech US Inc | - | BNT-221 | Oncology | Metastatic Melanoma | Company Press Release |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer